Skip to main content
Tech.euFundingExplorerBeta

Biorce

a TechBio company focused on transforming clinical trials through artificial intelligence

Biorce has raised €52M across 3 funding rounds from 12 investors, most recently a Series A round in Feb 2026. Based in Barcelona, Spain; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€52M
€52,418,919
Funding rounds
3
Investors
12
distinct backers
Active since
2024-11
latest 2026-02

Funding by year

EUR raised per year · 2026 YTD
Biorce — funding by year — interactive chart.
Data table
Biorce — funding by year
2024€3.5M
2025€5.0M
2026€44M

Signals

High confidence
Raise-next likelihood49
base rate 44% for Series A
  • ▲ In typical raise window
  • ▲ Up-round momentum
  • ▼ Low backer re-investment
Exit likelihood22
base rate 11% (2+ rounds)
  • ▲ €30M+ raised
  • ▼ Young (<3y)
  • ▲ Recently backed by strong-exit-track investors

Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

3 rounds

Similar companies

same sector or country

Global coverage: FundingData